The deconstruction of cellulose is essential for the conversion of biomass into fuels and chemicals. But cellulose, the most ...

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, announced ...

The festival, called The Arcades, is billed as “an undergraduate collage of music.” It began as a two-part course in UCSD’s ...

The Choose Europe for Science program will invest more than half a billion dollars between 2025 and 2027 to recruit ...

Carbyne, a one-dimensional chain of carbon atoms, is incredibly strong for being so thin, making it an intriguing possibility ...

Gubra releases its results for the first quarter of 2025. The key development in the quarter was the out-licensing agreement to AbbVie for our anti-obesity asset GUBamy (Amylin). A landmark deal ...

Today, Gubra releases its results for the first quarter of 2025. The key development in the quarter was the out-licensing agreement to AbbVie for our anti-obesity asset GUBamy (Amylin). A landmark ...

Farrah Khan, the former mayor of Irvine, has taken a senior vice president position with Quantum eMotion Corp., a Canadian-based company that recently opened its American subsidiary here to break into ...

Pune has released the information brochure for its MBBS course for 2025. Admission is based on NEET UG 2025 scores, and ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company ad Seasoned biotechnology industry ... living with devastating classical complement-mediated ...

Across the world, a growing number of physicians are recognizing that the traditional model of medicine — managing symptoms ...